Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Swanton

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Cyclin D mediates tolerance of genome-doubling in cancers with functional p53A Crockford, L P Zalmas, E Grönroos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket studyR Kurzrock, D W Bowles, H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2021
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation setE A Klein, D Richards, A Cohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine GlossaryL R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners FoundationS Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2015
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trialM Jamal-Hanjani, R A'Hern, N J Birkbak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)J Mateo, D Chakravarty, R Dienstmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conferenceC Swanton, J-C Soria, A Bardelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2020
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemicA Sud, M E Jones, J Broggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkersS Trebeschi, S G Drago, N J Birkbak, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Cyclin D mediates tolerance of genome-doubling in cancers with functional p53A Crockford, L P Zalmas, E Grönroos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket studyR Kurzrock, D W Bowles, H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2021
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation setE A Klein, D Richards, A Cohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine GlossaryL R Yates, J Seoane, C Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners FoundationS Peters, S Loi, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2015
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trialM Jamal-Hanjani, R A'Hern, N J Birkbak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)J Mateo, D Chakravarty, R Dienstmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2016
Consensus on precision medicine for metastatic cancers: a report from the MAP conferenceC Swanton, J-C Soria, A Bardelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2020
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemicA Sud, M E Jones, J Broggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2019
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkersS Trebeschi, S G Drago, N J Birkbak, et al.
Pageof 5